Graduated in Biological Sciences from the University of Brasília (UnB), with an M.Sc. in Biochemistry from the University of São Paulo (USP) and a Ph.D. in Molecular Genetics from the University of Queensland (Institute for Molecular Bioscience).

He was a researcher at the University of Cambridge in the Gurdon Institute and the Milner Therapeutics Institute, supported by the Royal Society and British Academy Newton International, Corpus Christi College Research, and Borysiewicz Biomedical Sciences Fellowships. He also worked in the industry as an entrepreneur, as well as a researcher at STORM Therapeutics.

He served as a visiting professor at several universities, including Campus Bio-Medico University of Rome (Unicampus) and Humanitas University – Medical School in Milan, as well as Karolinska Institutet and Uppsala University.

His research encompasses genome regulation in diseases and development and evolution, with a focus on RNAs and their chemical modifications. Currently, his research emphasis at Insper is on the intersection of molecular biology with bioengineering.